当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.
The Lancet ( IF 168.9 ) Pub Date : 2018-01-01 , DOI: 10.1016/s2213-2600(17)30424-1
David B Price , Roland Buhl , Adrian Chan , Daryl Freeman , Elizabeth Gardener , Clifford Godley , Kevin Gruffydd-Jones , Lorcan McGarvey , Ken Ohta , Dermot Ryan , Jörgen Syk , Ngiap Chuan Tan , TzeLee Tan , Mike Thomas , Sen Yang , Priyanka Raju Konduru , Marcus Ngantcha , Martina Stagno d'Alcontres , Therese S Lapperre

Chronic non-specific respiratory symptoms are difficult to manage. This trial aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids in patients with non-specific respiratory symptoms.

中文翻译:

分数呼出气一氧化氮可预测非特异性呼吸道症状和支气管扩张剂可逆性不明显的患者对吸入糖皮质激素的反应:一项随机对照试验。

慢性非特异性呼吸道症状难以控制。该试验旨在评估基线呼吸性一氧化氮分数(FeNO)与具有非特异性呼吸系统症状的患者对吸入皮质类固醇激素的反应之间的关系。
更新日期:2017-12-27
down
wechat
bug